IMP-111

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIMP-111

Drug Alias Namefully human monoclonal antibodies (Immune Pharmaceuticals)anti-CD44 monoclonal antibody (Immune Pharmaceuticals)antibody-dependent cellular phagocytosis stimulator (Immune Pharmaceuticals)IMP-111

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionCD44 antigen inhibitors

TargetsCD44 antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmune Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmune Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A